Nearly 90 percent of the opinions issued by the federal courts of appeal are unpublished and lack precedential effect, and where these cases lay out new legal rules, this phenomenon cannot be reconciled with the Supreme Court’s settled retroactivity jurisprudence. This article highlights this inconsistency and proposes use of the “new rule” construct as a mechanism for differentiating those opinions that may be designated nonprecedential from those that may not.
The Individuals with Disabilities Education Act contains provisions that ostensibly guard against disproportionate suspending and expelling school students with disabilities. This article demonstrates that these provisions are woefully inadequate to achieve their goal. It argues that current flaws can be mitigated by altering the burden of proof and expanding the type of data that schools must gather and rely upon in making decisions regarding the exclusion of students with disabilities.
Social value in the drug industry comes from ensuring that consumers get the drugs they need, but also from encouraging new drug development. In the United States, where new drug development is largely in the hands of drug manufacturers, these objectives directly conflict. To achieve a suitable balance, this Comment proposes two changes to the pharmaceutical market that ensure reasonable coverage by insurance companies and reasonable prices from drug manufacturers.
This comment focuses on the Fourth Amendment implications of the remote use of lethal force. It examines the current constitutional standard for analyzing the reasonableness of the use of force under Graham v. Connor and discusses why it falls short in situations in which the officer has time to consider her options, as any officer engaging an individual via remotely controlled vehicle undoubtedly does.